Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board remands the Veteran's claim for service connection for psoriasis to correct a pre-decisional duty-to-assist error.

The Board granted service connection for skin cancer and a 50 percent disability rating for PTSD, while dismissing claims for compensable ratings for neurodermatitis and a right hip disability, and denying an increased rating for bilateral hearing loss.

The Board remands the claims for a recurrent skin disability, sleep disability, respiratory disability, esophageal disability, left ankle disability, gastrointestinal disability, hypertension, and lumbar spine disability to the Agency of Original Jurisdiction (AOJ) for further development.

The Board remands the claims for service connection for various conditions, including carpal tunnel syndrome and a cervical spine disability, due to duty-to-assist errors.

The Board remands the claim for service connection for a skin condition, including nonmelanoma skin cancer (NMSC), basal cell carcinoma, actinic dermatitis, actinic and seborrheic keratosis, and cherry angiomas, to obtain additional medical opinions regarding their etiology.

The Veteran's claim for an increased rating for GERD was granted, but no earlier effective dates were granted for the other service connection claims.

The Board denied the veteran's claims for earlier effective dates and increased ratings, finding that the earliest possible effective date was provided.

The Veteran's service-connected disabilities, including right and left knee disabilities, lumbar spine disability, and bilateral lower extremity radiculopathy, require care and assistance on a regular basis.

The Board granted service connection for tinnitus and pseudofolliculitis barbae (PFB) but denied service connection for somatic symptom disorder. The Board also denied increased ratings for bilateral hearing loss and PTSD.

The Board granted service connection for acquired psychiatric disabilities, to include PTSD and anxiety disorder, cervical spine pain, onychomycosis, and skin conditions. The claim was denied for hypertension, coronary artery disease, and bilateral hearing loss.

The Board denied a disability rating in excess of 70 percent for somatic symptom disorder, denied ratings in excess of 20 percent for left and right knee patellofemoral syndrome, granted separate 10 percent ratings for instability in both knees, denied a compensable rating for allergic rhinitis with residuals of septoplasty, denied service connection for bilateral hearing loss but granted service connection for bilateral restless leg syndrome, left Achilles tendonitis with plantar fasciitis, and eczema.

The Board remands the claims for service connection as they require further development, including new medical opinions and additional evidence.

The Board remands the claims for service connection for spinal stenosis with degenerative arthritis of the cervical spine and a skin condition, to include eczema, as there were errors in the duty to assist that need correction.

The Board remands the case for an addendum opinion addressing whether the Veteran's chronic scalp folliculitis is related to his in-service exposure to herbicide agents.

The Board denied the veteran's claims for increased ratings and service connection, except for pseudofolliculitis barbae and left sciatic radicular pain and paresthesia of the left leg as secondary to a service-connected condition.

The Board remands the claims for service connection for various conditions, including psychiatric disorders and chronic fatigue syndrome, due to a need for additional evidence and examinations.

The Board remands the claims for additional VA examinations to determine the current nature and severity of the Veteran's conditions.

The appeal for an increased rating for plantar keratoderma was dismissed due to a procedural defect involving concurrent election of review options.

The Board denied service connection for tinea pedis as it is not related to the Veteran's service or his service-connected bilateral pes planus.

The Board denied a combined rating in excess of 70 percent and an increased rating for Pseudofolliculitis barbe (PFB) based on the evidence of record.